Brief: Walmer Capital Corp provides corporate update
15/10/2015 16:45
Oct 15 (Reuters) - Walmer Capital Corp WALh.V : * Provides corporate update * Says company is still committed to pursuing its qualifying transaction as soon as possible * Source text for Eikon ID:nCCN1RBMjl * Further company coverage WALh.V ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Nurexone Biologic
See all newsBrief: Nurexone Announces Binding MoU With Made Scientific For U.S. Gmp Manufacturing And Commercial Supply Partnership
Brief: Corporate Updates – Nurexone Appoints Mr. David Stolick To The Board Of Directors
Brief: Exo-Top, Nurexone’S Wholly Owned U.S. Subsidiary, Enters Into Binding MoU For Naïve Exosome Distribution In Mexico
Brief: Nurexone Biologic’S U.S. Subsidiary Exo-Top And Florida-Based Bioxtek Sign Strategic Loi For Exosome Manufacturing And Commercialization
Brief: Nurexone Strengthens U.S. Manufacturing Strategy Through Exo-Top Sublicense Agreement